Showing results out of
Scientists have discovered that gut bacteria can alter molecular signatures in the brain, using a brand new method to study how carbohydrates modify proteins.
SCIENCE & TECHNOLOGY2025
science-technology
Scientists share their experiences of creating stunning images at the EMBL Imaging Centre.
CONNECTIONS2025
connections
EMBL Heidelberg researchers compared the effect of drugs on isolated bacteria versus those growing in communities. This is the first study showing that bacteria are more resilient when in community due to cross-protection strategies. This could help researchers design more efficient therapies.
SCIENCE & TECHNOLOGY2024
science-technology
Study shows that gut bacteria can metabolise carcinogens and cause them to accumulate in distant organs, leading to tumour development.
SCIENCE & TECHNOLOGY2024
science-technology
Three EMBL scientists received this year’s ERC Starting Grants, and will be awarded €1.5 million over five years to carry out research projects.
EMBL ANNOUNCEMENTSLAB MATTERS2022
embl-announcementslab-matters
A new collaborative study led by EMBL group leaders Kiran Patil, Nassos Typas, and Peer Bork has found that common medications accumulate in human gut bacteria. This process reduces drug effectiveness and affects the metabolism of common gut microbes, thereby altering the gut microbiome.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
The EMBL Imaging Centre is preparing for external user access, after an on-time and on-budget build and handover to the science team.
CONNECTIONSLAB MATTERS2021
connectionslab-matters
EMBL Director Matthias Hentze describes the Environmental Research Initiative: a community effort to solve global environmental challenges.
LAB MATTERSPEOPLE & PERSPECTIVES2021
lab-matterspeople-perspectives
The Gesellschaft für Biochemie und Molekularbiologie has awarded a FEBS Anniversary Prize to Michael Zimmermann for his gut microbiome research.
EMBL ANNOUNCEMENTSLAB MATTERS2021
embl-announcementslab-matters
Michael Zimmermann's group will investigate how gut microbes affect the body’s response to drugs.
PEOPLE & PERSPECTIVES2019
people-perspectivesscience
No results found